Milagros Saavedra-Samillán
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Milagros Saavedra-Samillán has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Rafael Tapia-Limonchi
Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú
4 shared publications - Stella M. Chenet
Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas
4 shared publications - Julio Sandoval-Bances
Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas
2 shared publications - Luis M. Rojas
Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas
2 shared publications - T. Pershing Bustamante Chauca
Dirección Regional de Salud de Amazonas (DIRESA), Chachapoyas, Perú
2 shared publications - Carmen Inés Gutierrez De Carrillo
Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru
1 shared publication
Latest Publications
- Open Access
- 27 August 2026
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (11) , 1096-1106
Neglected arboviruses in South America: clinical manifestations and diagnostic challenges
In South America, the arboviruses that are most noted are those that lead to dengue, Zika, and chikungunya. Nevertheless, there are additional arboviruses that trigger outbreaks, yet do not receive adequate attention, including Oropouche virus (OROV), Mayaro virus (MAYV), Saint Louis Encephalitis virus, Madariaga virus (MADV), and Rocío virus (ROCV). A rapid review was conducted using the databases PubMed, LILACS, Scopus, and Google Scholar. This analysis focused on studies that outline the clinical signs and diagnostic methods of neglected arboviruses impacting human populations in South America. A total of 38 studies met the inclusion criteria. Most reports focused on OROV and MAYV, whereas only a few studies described MADV and ROCV. Brazil accounted for the largest proportion of studies, followed by Peru. Across the reviewed literature, these arboviruses were associated with a broad clinical spectrum, ranging from non-specific febrile illness to severe neurological disease and congenital complications. Diagnostic approaches included serological assays, viral isolation or neutralization tests, and molecular methods such as RT-PCR. The increasing spread of these under-reported arboviruses in South America requires strengthening monitoring systems, optimizing access to specific diagnostics, and training healthcare personnel to identify these infections early and manage them appropriately.
- 27 August 2026
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (11) , 1096-1106
Open AccessNeglected arboviruses in South America: clinical manifestations and diagnostic challenges
In South America, the arboviruses that are most noted are those that lead to dengue, Zika, and chikungunya. Nevertheless, there are additional arboviruses that trigger outbreaks, yet do not receive adequate attention, including Oropouche virus (OROV), Mayaro virus (MAYV), Saint Louis Encephalitis virus, Madariaga virus (MADV), and Rocío virus (ROCV). A rapid review was conducted using the databases PubMed, LILACS, Scopus, and Google Scholar. This analysis focused on studies that outline the clinical signs and diagnostic methods of neglected arboviruses impacting human populations in South America. A total of 38 studies met the inclusion criteria. Most reports focused on OROV and MAYV, whereas only a few studies described MADV and ROCV. Brazil accounted for the largest proportion of studies, followed by Peru. Across the reviewed literature, these arboviruses were associated with a broad clinical spectrum, ranging from non-specific febrile illness to severe neurological disease and congenital complications. Diagnostic approaches included serological assays, viral isolation or neutralization tests, and molecular methods such as RT-PCR. The increasing spread of these under-reported arboviruses in South America requires strengthening monitoring systems, optimizing access to specific diagnostics, and training healthcare personnel to identify these infections early and manage them appropriately.
- Open Access
- 17 May 2025
- Published by Elsevier in Acta Tropica
- Vol. 267, 107659
Exploring spatiotemporal dynamics and climatic effects on dengue in Amazonas, Peru during 2000–2023
- 17 May 2025
- Published by Elsevier in Acta Tropica
- Vol. 267, 107659
Open AccessExploring spatiotemporal dynamics and climatic effects on dengue in Amazonas, Peru during 2000–2023
- Open Access
- 30 September 2023
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 43 (3) , 352-359
Caracterización molecular del dominio de la hélice del gen k13 de Plasmodium falciparum en muestras de comunidades nativas de Condorcanqui, Amazonas, Perú
Introducción. La resistencia de Plasmodium falciparum a diferentes fármacos antipalúdicos es un obstáculo para eliminar la enfermedad. El genotipo resistente de P. falciparum a la artemisinina puede evaluarse examinando los polimorfismos en el dominio de la hélice del gen Pfk13. La Organización Mundial de la Salud recomienda utilizar estas mutaciones como marcadores moleculares para detectar la resistencia a la artemisinina en países donde la malaria por P. falciparum es endémica.Objetivo. Identificar mutaciones relacionadas con la resistencia a artemisinina presentes en el dominio de la hélice del gen k13 de P. falciparum.Materiales y métodos. Mediante la detección pasiva de casos, se recolectaron 51 muestras positivas por microscopía para Plasmodium, provenientes de seis comunidades del distrito de Río Santiago en Condorcanqui, Amazonas. Se realizó la confirmación molecular de la especie mediante PCR en tiempo real y el dominio de la hélice del gen Pfk13 se amplificó y secuenció por electroforesis capilar. Las secuencias obtenidas se compararon con la cepa de referencia 3D7 de fenotipo silvestre.Resultados. Se confirmó un total de 51 muestras positivas para P. falciparum, provenientes de las comunidades de Ayambis, Chapiza, Palometa, Muchinguis, Alianza Progreso y Caterpiza. Después del alineamiento de las secuencias de ADN, se determinó que las muestras no presentaron mutaciones asociadas con resistencia en el gen K13. Discusión. Los resultados obtenidos son coherentes con estudios similares realizados en otros países de Sudamérica, incluyendo Perú. Estos datos proporcionan una línea base para la vigilancia molecular de resistencia a artemisinina en la región Amazonas y refuerzan la eficacia de la terapia combinada con artemisinina en esta área.
- 30 September 2023
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 43 (3) , 352-359
Open AccessCaracterización molecular del dominio de la hélice del gen k13 de Plasmodium falciparum en muestras de comunidades nativas de Condorcanqui, Amazonas, Perú
Introducción. La resistencia de Plasmodium falciparum a diferentes fármacos antipalúdicos es un obstáculo para eliminar la enfermedad. El genotipo resistente de P. falciparum a la artemisinina puede evaluarse examinando los polimorfismos en el dominio de la hélice del gen Pfk13. La Organización Mundial de la Salud recomienda utilizar estas mutaciones como marcadores moleculares para detectar la resistencia a la artemisinina en países donde la malaria por P. falciparum es endémica.Objetivo. Identificar mutaciones relacionadas con la resistencia a artemisinina presentes en el dominio de la hélice del gen k13 de P. falciparum.Materiales y métodos. Mediante la detección pasiva de casos, se recolectaron 51 muestras positivas por microscopía para Plasmodium, provenientes de seis comunidades del distrito de Río Santiago en Condorcanqui, Amazonas. Se realizó la confirmación molecular de la especie mediante PCR en tiempo real y el dominio de la hélice del gen Pfk13 se amplificó y secuenció por electroforesis capilar. Las secuencias obtenidas se compararon con la cepa de referencia 3D7 de fenotipo silvestre.Resultados. Se confirmó un total de 51 muestras positivas para P. falciparum, provenientes de las comunidades de Ayambis, Chapiza, Palometa, Muchinguis, Alianza Progreso y Caterpiza. Después del alineamiento de las secuencias de ADN, se determinó que las muestras no presentaron mutaciones asociadas con resistencia en el gen K13. Discusión. Los resultados obtenidos son coherentes con estudios similares realizados en otros países de Sudamérica, incluyendo Perú. Estos datos proporcionan una línea base para la vigilancia molecular de resistencia a artemisinina en la región Amazonas y refuerzan la eficacia de la terapia combinada con artemisinina en esta área.
- Open Access
- 9 July 2022
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 22 (3) , 533-539
Malaria and COVID-19 in native communities of Amazonas, Peru
Introduction In recent years, the number of malaria cases in native communities from Condorcanqui, Amazonas has considerably increased. Plasmodium vivax malaria is endemic in the region and the re-introduction of P. falciparum was reported in 2019. Methods Here, we compiled and analyzed malaria and COVID-19 data reported by the Regional Direction of Health (DIRESA) during the 2020. Additionally, we performed an odds ratio analysis to evaluate significant associations between COVID-19 symptoms and previous malaria infections. Results In 2020, 1547 malaria (97% were P. vivax) and 5968 COVID-19 cases were reported. Furthermore, 96 patients got COVID-19 after getting a malaria infection. From these, 87 were symptomatic (90.6%), and mostly adults, ages 30 to 59 (62.3%). Also, we found that malaria previous infections represent a risk for the presence of symptoms such as fever, cough, throat pain, and respiratory difficulty. Nevertheless, there was no significant association between these cases and hospitalization or death. Conclusion Our analysis suggests that previous malaria infections might affect COVID-19 symptomatology, which highlights the importance of a continuing control and surveillance malaria program to avoid potential syndemics with COVID-19.
- 9 July 2022
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 22 (3) , 533-539
Open AccessMalaria and COVID-19 in native communities of Amazonas, Peru
Introduction In recent years, the number of malaria cases in native communities from Condorcanqui, Amazonas has considerably increased. Plasmodium vivax malaria is endemic in the region and the re-introduction of P. falciparum was reported in 2019. Methods Here, we compiled and analyzed malaria and COVID-19 data reported by the Regional Direction of Health (DIRESA) during the 2020. Additionally, we performed an odds ratio analysis to evaluate significant associations between COVID-19 symptoms and previous malaria infections. Results In 2020, 1547 malaria (97% were P. vivax) and 5968 COVID-19 cases were reported. Furthermore, 96 patients got COVID-19 after getting a malaria infection. From these, 87 were symptomatic (90.6%), and mostly adults, ages 30 to 59 (62.3%). Also, we found that malaria previous infections represent a risk for the presence of symptoms such as fever, cough, throat pain, and respiratory difficulty. Nevertheless, there was no significant association between these cases and hospitalization or death. Conclusion Our analysis suggests that previous malaria infections might affect COVID-19 symptomatology, which highlights the importance of a continuing control and surveillance malaria program to avoid potential syndemics with COVID-19.